Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Food Scene
Community Directory
Community Service
Restaurant Guide
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Horizons
Outdoor Guide
Progress
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2022 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(OP:
POLBF
)
0.1150
UNCHANGED
Last Price
Updated: 9:30 AM EST, Feb 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.1150
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1150
Today's Range
0.1150 - 0.1150
52wk Range
0.0888 - 0.1050
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
March 09, 2023
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
Via
News Direct
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
March 09, 2023
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human...
Via
TheNewswire.com
Performance
YTD
+14.89%
+14.89%
1 Month
N/A
N/A
3 Month
+14.89%
+14.89%
6 Month
+43.93%
+43.93%
1 Year
+15.00%
+15.00%
More News
Read More
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
March 02, 2023
Via
News Direct
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
March 02, 2023
Via
TheNewswire.com
Poolbeg Pharma "really open" to different types of deal for POLB 001
March 01, 2023
Via
News Direct
Poolbeg Pharma PLC Announces Strategic Expansion of POLB 001 into Oncology
January 16, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Positive Initial Data Analysis in POLB 001 Trial
January 09, 2023
Via
ACCESSWIRE
Poolbeg Identifies Novel RSV Drug Candidates
December 21, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Metabolic Diseases Oral Delivery Licence Signed
December 14, 2022
Via
ACCESSWIRE
Poolbeg Pharma "really open" to different types of deal for POLB 001
March 01, 2023
Via
TheNewswire.com
Poolbeg Pharma announces expansion of POLB 001 into oncology
January 18, 2023
Via
News Direct
Topics
Intellectual Property
Exposures
Intellectual Property
Poolbeg Pharma announces expansion of POLB 001 into oncology
January 18, 2023
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Poolbeg Pharma upbeat on preliminary influenza drug results
January 09, 2023
Via
News Direct
Poolbeg Pharma upbeat on preliminary influenza drug results
January 09, 2023
Via
TheNewswire.com
Poolbeg Pharma PLC - POLB 001 LPS Human Challenge Trial Completed
December 12, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Influenza AI model build completed
November 29, 2022
Via
ACCESSWIRE
Poolbeg-led Consortium Awarded EUR 2.3m Grant
November 15, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Capital Markets Day
November 17, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces AI Programme Yields Novel RSV Drug Targets
November 08, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces CEO Share Purchase
October 06, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 US Patent update
October 04, 2022
Via
ACCESSWIRE
Poolbeg Licence of Melioidosis Vaccine Candidate
September 21, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces HC Wainwright Global Investment Conference
September 12, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Appointment of Joint Broker
July 29, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Appointment of Joint Broker
July 29, 2022
From
Poolbeg Pharma PLC
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
